Effect of terminal renal failure on the ratio of free to total prostate- specific antigen

Tumor Biology

Volumn 19, Issue 2, 1998, Pages 113-117

  Douville, Pierre ^a   Tiberi, Marco ^b  

^a LAVAL UNIVERSITY   (Canada)

^b Boehringer Mannheim Canada   (Canada)

Author keywords

Free prostate specific antigen; Hemodialysis; Prostate specific antigen; Renal failure

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031929012     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029981     Document Type: Article

References (10)

1. Leinonen J, Zhang WM, Stenman UH: Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155:1099-1103.
2. Monath JR, Burkart JM, Freedman BI, Pittaway DE, Russell GB, Assimos DG: Effects of hemodialysis on prostate-specific antigen. Urology 1993;42:398-400.
3. Harper L, McIntyre CW, MacDougall IC, Meyer P, Raine AE, Baker LR: Prostate-specific antigen levels in patients receiving long-term dialysis. Br J Urol 1995;76:482-483.
4. Kabalin JN, Hornberger JC: Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis. Urology 1991;37:308-310.
5. Stenman UH, Leinonen J, Alfthan H, et al: A complex between prostate-specific antigen and alpha-1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer. Cancer Res 1991;51/1:222-226.
6. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-1220.
7. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen T, Abrahamsson PA, Stenman UH, Dowell B, Lovgren T, Lilja H: Free-complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995;54:1090-1095.
8. Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, et al: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-194.
9. Richardson TD, Wojno KJ, Liang LW, Giacherio DA, England BG, Henricks WH, Schork A, Oesterling JE: Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy. Urology 1996;48:40-44.
10. Honda SAA, Goldstein AP, Morita T, Sugiyama C, Cody L, Rios CN, Bhagavan NV: Prostate-specific antigen concentrations in serum in acute illnesses. Clin Chem 1996;42: 1785-1788.